Top Story

Melatonin at mealtimes may increase type 2 diabetes risk in people with gene variant

October 7, 2015

Taking melatonin close to mealtimes may put people with the genetic variant MTNR1B at a greater risk for developing type 2 diabetes, according to recent study findings published in Metabolism.

“Our work is the first to show that a person’s genetic profile could impact their ability to tolerate glucose when they take melatonin,” Frank Scheer, PhD, associate professor of medicine at Harvard Medical school and director of the medical chronobiology at Brigham and Women’s Hospital, said in a press release.

In the Journals

New guideline stresses benefits of HT for menopausal symptoms

October 7, 2015
Hormone therapy is effective for most women aged up to 60 years or less than 10 years past the onset of menopause who experience bothersome hot flashes and other…
Michelle Moniz In the Journals

More Medicaid agencies covering contraceptive insertion immediately postpartum

October 6, 2015
Since South Carolina began providing additional payment for the insertion of long-acting reversible contraceptives immediately following delivery in 2012, at least 14…
In the Journals

Estradiol-mediated effects on insulin action depend on timing of postmenopausal HT

October 5, 2015
In early postmenopausal women, the incidence of type 2 diabetes can be reduced by the estradiol-mediated effects on insulin action, according to recent study findings…
More News Headlines »
Meeting News Coverage
Wendy Wolfman

Transdermal estrogen, intermittent progesterone safe, effective for menopause symptoms

October 2, 2015
Reducing the dosage of progesterone in postmenopausal women on low-dose transdermal hormone therapies provided safe and…
More »
Meeting News Coverage Video
4131397887001 th

Vlog: Global endocrinology community gathers for ICE/ENDO 2014

June 21, 2014
Ronald Tamler, MD, PhD, MBA, clinical director of the Mount Sinai Diabetes Center and a member of the Endocrine Today
More »
Current Issues
View the Current Issues